celecoxib has been researched along with Adenocarcinoma, Alveolar in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, B | 1 |
| Jin, K | 1 |
| Jiang, T | 1 |
| Wang, L | 1 |
| Shen, S | 1 |
| Luo, Z | 1 |
| Tuo, Y | 1 |
| Liu, X | 1 |
| Hu, Y | 1 |
| Pang, Z | 1 |
1 other study available for celecoxib and Adenocarcinoma, Alveolar
| Article | Year |
|---|---|
Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents, Phytogenic; Celecox | 2017 |